Provident Investment Management Boosted By $20.87 Million Its Abbott Labs (ABT) Position; Shorts at Emerge Energy Services LP (EMES) Lowered By 8.2%

November 14, 2017 - By Ellis Scott

Provident Investment Management Inc increased Abbott Labs (ABT) stake by 4437.14% reported in 2017Q2 SEC filing. Provident Investment Management Inc acquired 434,884 shares as Abbott Labs (ABT)’s stock

declined 3.42%. The Provident Investment Management Inc holds 444,685 shares with $21.62 million value, up from 9,801 last quarter. Abbott Labs now has $96.26 billion valuation. It closed at $55.3 lastly. It is down 15.90% since November 14, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

Emerge Energy Services LP (NYSE:EMES) had a decrease of 8.2% in short interest. EMES’s SI was 1.88 million shares in November as released by FINRA. Its down 8.2% from 2.05 million shares previously. With 394,600 avg volume, 5 days are for Emerge Energy Services LP (NYSE:EMES)’s short sellers to cover EMES’s short positions. The SI to Emerge Energy Services LP’s float is 9.85%. The stock increased 0.11% or $0.01 on November 13, reaching $9.11. About 40 shares traded. Emerge Energy Services LP (NYSE:EMES) has risen 243.72% since November 14, 2016 and is uptrending. It has outperformed by 227.02% the S&P500.

Investors sentiment increased to 1.5 in Q2 2017. Its up 0.18, from 1.32 in 2017Q1. It increased, as 8 investors sold Emerge Energy Services LP shares while 10 reduced holdings. 8 funds opened positions while 19 raised stakes. 8.35 million shares or 15.41% less from 9.87 million shares in 2017Q1 were reported. California Public Employees Retirement System invested 0% of its portfolio in Emerge Energy Services LP (NYSE:EMES). Bankshares Of America De has invested 0% in Emerge Energy Services LP (NYSE:EMES). Blair William And Il reported 0% stake. Pnc Serv Grp holds 0% or 4,500 shares. Missouri-based Stifel Fin has invested 0% in Emerge Energy Services LP (NYSE:EMES). Nelson Van Denburg & Campbell Wealth Mgmt Group Limited Co invested in 0% or 400 shares. 105,019 are owned by Barclays Public Ltd Com. Citadel Advsr Limited Liability stated it has 78,758 shares. The Ohio-based Parkwood Ltd Limited Liability Company has invested 0.08% in Emerge Energy Services LP (NYSE:EMES). Royal Bank & Trust Of Canada, a Ontario – Canada-based fund reported 25,187 shares. Manufacturers Life Insurance The invested in 0% or 703 shares. Credit Suisse Ag has 473,496 shares for 0% of their portfolio. Tocqueville Asset Mngmt Lp stated it has 0.01% of its portfolio in Emerge Energy Services LP (NYSE:EMES). Wells Fargo Mn owns 32,144 shares. Moreover, Wfg Advsrs Limited Partnership has 0% invested in Emerge Energy Services LP (NYSE:EMES).

Emerge Energy Services LP owns, operates, acquires and develops a portfolio of energy service assets. The company has market cap of $274.69 million. The Firm operates through Sand segment. It currently has negative earnings. The Firm conducts its Sand activities through its subsidiary, Superior Silica Sands LLC .

Among 12 analysts covering Emerge Energy Services (NYSE:EMES), 6 have Buy rating, 2 Sell and 4 Hold. Therefore 50% are positive. Emerge Energy Services had 36 analyst reports since July 30, 2015 according to SRatingsIntel. Wunderlich maintained Emerge Energy Services LP (NYSE:EMES) on Monday, May 16 with “Hold” rating. Robert W. Baird upgraded the shares of EMES in report on Thursday, July 30 to “Outperform” rating. The firm earned “Neutral” rating on Friday, October 23 by Seaport Global Securities. The firm earned “Sell” rating on Thursday, November 5 by Stifel Nicolaus. On Thursday, October 1 the stock rating was maintained by Wunderlich with “Hold”. Goldman Sachs downgraded the stock to “Neutral” rating in Friday, September 11 report. The rating was maintained by Cowen & Co on Friday, July 7 with “Hold”. The firm has “Hold” rating by Cowen & Co given on Wednesday, October 18. The firm earned “Buy” rating on Thursday, September 29 by Wunderlich. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, July 13.

Among 24 analysts covering Abbott Laboratories (NYSE:ABT), 14 have Buy rating, 0 Sell and 10 Hold. Therefore 58% are positive. Abbott Laboratories had 87 analyst reports since July 24, 2015 according to SRatingsIntel. Jefferies upgraded the shares of ABT in report on Monday, December 7 to “Buy” rating. The company was maintained on Monday, October 2 by BMO Capital Markets. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by Jefferies on Tuesday, October 10. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Friday, October 9 with “Outperform” rating. Barclays Capital maintained Abbott Laboratories (NYSE:ABT) on Thursday, April 20 with “Overweight” rating. The rating was reinitiated by Jefferies on Thursday, June 29 with “Buy”. The stock has “Neutral” rating by UBS on Tuesday, September 22. Cowen & Co maintained it with “Buy” rating and $68.0 target in Wednesday, October 18 report. The firm has “Buy” rating given on Tuesday, June 21 by Edward Jones. Barclays Capital maintained it with “Overweight” rating and $64 target in Thursday, October 19 report.

Since June 15, 2017, it had 0 buys, and 1 insider sale for $26,482 activity. $26,482 worth of stock was sold by Watkin Jared on Thursday, June 15.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>